US 11807629
Polymorphs of Selinexor
granted A61KA61K31/497A61P
Quick answer
US patent 11807629 (Polymorphs of Selinexor) held by Karyopharm Therapeutics Inc. expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Karyopharm Therapeutics Inc.
- Grant date
- Tue Nov 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/497, A61P, A61P35/00